Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

Abstract

The present studies confirm the potent dose-dependent antitumor activity of TSA against breast cancer in vitro and in vivo, strongly supporting HDAC as a molecular target for anticancer therapy in breast cancer.